nyse:tri
|
38830
|
Apr 14th, 2024 12:00AM
|
Discovery Logic
|
1.9K
|
23.00
|
Open
|
|
Apr 14th, 2024 01:45AM
|
Apr 14th, 2024 01:45AM
|
Discovery Logic, a Thomson Reuters business, "connects the dots" across scientific and business databases to inform R&D investment decisions, visualize trends, locate experts and evaluate project and portfolio performance. We specialize in mining and refining knowledge from large scientific databases and have a rich history of accomplishment, achieving new technical and scientific breakthroughs with virtually every project.
Our latest data platform, ScienceWire® v3, combines Discovery Logic's search and data mining technology, advanced algorithms and inter-source linkages among real-time open-source and proprietary databases including cross-agency R&D grant data, patents, citations, journals and news. We maintain and update these databases, create and apply algorithms to extract and link information across the databases, and deliver custom solutions that allow clients to apply the data to address their business needs.
Discovery Logic is agile, flexible, fast, and open to new challenges. We maintain an open organizational structure and free flows of communication. We hire extraordinarily talented individuals and give them the freedom to innovate. We pursue new opportunities quickly, challenging ourselves and our clients to think boldly.
|
Open
|
science, database, research, investment, metrics, grants, LRP, and loan repayment
|
Open
|
1375 Piccard Drive
|
Rockville
|
MD
|
US
|
20850
|
|
Thomson Reuters
|
Consumer Services
|
Media
|
nyse:tri
|
1400
|
Apr 14th, 2024 12:00AM
|
Thomson Reuters
|
1.7M
|
33104
|
Open
|
|
Apr 14th, 2024 01:45AM
|
Apr 14th, 2024 01:45AM
|
Thomson Reuters is the world’s leading provider of news and information-based tools to professionals. Our worldwide network of journalists and specialist editors keep customers up to speed on global developments, with a particular focus on legal, regulatory and tax changes.
Our customers operate in complex arenas that move society forward — tax, law, compliance, government, media. In a disruptive digital age, we help professionals reinvent themselves.
Thomson Reuters shares are listed on the Toronto and New York Stock Exchanges (symbol: TRI).
|
Open
|
Intelligent Information, Accounting, Legal, Tax, Media, Technology, and News
|
Open
|
19 Duncan Street
|
Toronto
|
ON
|
CA
|
M5H 3G6
|
|
Thomson Reuters
|
Consumer Services
|
Media
|
nyse:tri
|
1507557
|
Apr 14th, 2024 12:00AM
|
Reuters Events Pharma
|
43K
|
14.00
|
Open
|
|
Apr 14th, 2024 01:45AM
|
Apr 14th, 2024 01:45AM
|
Reuters Events Pharma is a hub for senior-level pharma executives, patient advocacy groups and other health experts to exchange ideas and stay up to date with shifting trends and practices within the pharmaceutical industry. We provide industry-focused commentary, events, reports, and other valuable expert-driven content, around several key topic areas: marketing, commercial, data & analytics, patient engagement, patient advocacy, medical affairs, market access, RWE and clinical.
Our ultimate aim is to facilitate positive change through discussion and debate, enabling dialogue within the industry and driving the positive benefits that pharmaceuticals can offer. We actively respond to the aims and interests of our audience, so please get in touch if you think we can do even more.
One of Reuters Events Pharma's biggest strengths is to be able to gather opinion directly from industry executives themselves rather than the consultants and suppliers you see forming the majority of opinions in most pharmaceutical magazines and journals. We leverage this to provide unique features and thought-leadership, across the world.
Reuters Events is part of Reuters News.
|
Open
|
Newsletters, Events, Conferences, Reports, Market Intelligence, pharma marketing, digital pharma, whitepapers, virtual events, hybrid events, medical affairs, business intelligence, business insights, conferences, and webinars
|
Open
|
7-9 Fashion St
|
London
|
|
GB
|
E1 6PX
|
|
Thomson Reuters
|
Consumer Services
|
Media
|
nyse:tri
|
1507557
|
Apr 13th, 2024 12:00AM
|
Reuters Events Pharma
|
43K
|
14.00
|
Open
|
|
Apr 13th, 2024 01:09AM
|
Apr 13th, 2024 01:29PM
|
Reuters Events Pharma is a hub for senior-level pharma executives, patient advocacy groups and other health experts to exchange ideas and stay up to date with shifting trends and practices within the pharmaceutical industry. We provide industry-focused commentary, events, reports, and other valuable expert-driven content, around several key topic areas: marketing, commercial, data & analytics, patient engagement, patient advocacy, medical affairs, market access, RWE and clinical.
Our ultimate aim is to facilitate positive change through discussion and debate, enabling dialogue within the industry and driving the positive benefits that pharmaceuticals can offer. We actively respond to the aims and interests of our audience, so please get in touch if you think we can do even more.
One of Reuters Events Pharma's biggest strengths is to be able to gather opinion directly from industry executives themselves rather than the consultants and suppliers you see forming the majority of opinions in most pharmaceutical magazines and journals. We leverage this to provide unique features and thought-leadership, across the world.
Reuters Events is part of Reuters News.
|
Open
|
Newsletters, Events, Conferences, Reports, Market Intelligence, pharma marketing, digital pharma, whitepapers, virtual events, hybrid events, medical affairs, business intelligence, business insights, conferences, and webinars
|
Open
|
7-9 Fashion St
|
London
|
|
GB
|
E1 6PX
|
|
Thomson Reuters
|
Consumer Services
|
Media
|
nyse:tri
|
38830
|
Apr 13th, 2024 12:00AM
|
Discovery Logic
|
1.9K
|
23.00
|
Open
|
|
Apr 13th, 2024 01:09AM
|
Apr 13th, 2024 01:29PM
|
Discovery Logic, a Thomson Reuters business, "connects the dots" across scientific and business databases to inform R&D investment decisions, visualize trends, locate experts and evaluate project and portfolio performance. We specialize in mining and refining knowledge from large scientific databases and have a rich history of accomplishment, achieving new technical and scientific breakthroughs with virtually every project.
Our latest data platform, ScienceWire® v3, combines Discovery Logic's search and data mining technology, advanced algorithms and inter-source linkages among real-time open-source and proprietary databases including cross-agency R&D grant data, patents, citations, journals and news. We maintain and update these databases, create and apply algorithms to extract and link information across the databases, and deliver custom solutions that allow clients to apply the data to address their business needs.
Discovery Logic is agile, flexible, fast, and open to new challenges. We maintain an open organizational structure and free flows of communication. We hire extraordinarily talented individuals and give them the freedom to innovate. We pursue new opportunities quickly, challenging ourselves and our clients to think boldly.
|
Open
|
science, database, research, investment, metrics, grants, LRP, and loan repayment
|
Open
|
1375 Piccard Drive
|
Rockville
|
MD
|
US
|
20850
|
|
Thomson Reuters
|
Consumer Services
|
Media
|
nyse:tri
|
1400
|
Apr 13th, 2024 12:00AM
|
Thomson Reuters
|
1.7M
|
33103
|
Open
|
|
Apr 13th, 2024 01:09AM
|
Apr 13th, 2024 01:29PM
|
Thomson Reuters is the world’s leading provider of news and information-based tools to professionals. Our worldwide network of journalists and specialist editors keep customers up to speed on global developments, with a particular focus on legal, regulatory and tax changes.
Our customers operate in complex arenas that move society forward — tax, law, compliance, government, media. In a disruptive digital age, we help professionals reinvent themselves.
Thomson Reuters shares are listed on the Toronto and New York Stock Exchanges (symbol: TRI).
|
Open
|
Intelligent Information, Accounting, Legal, Tax, Media, Technology, and News
|
Open
|
19 Duncan Street
|
Toronto
|
ON
|
CA
|
M5H 3G6
|
|
Thomson Reuters
|
Consumer Services
|
Media
|
nyse:tri
|
38830
|
Apr 12th, 2024 12:00AM
|
Discovery Logic
|
1.9K
|
23.00
|
Open
|
|
Apr 12th, 2024 01:20AM
|
Apr 12th, 2024 10:30AM
|
Discovery Logic, a Thomson Reuters business, "connects the dots" across scientific and business databases to inform R&D investment decisions, visualize trends, locate experts and evaluate project and portfolio performance. We specialize in mining and refining knowledge from large scientific databases and have a rich history of accomplishment, achieving new technical and scientific breakthroughs with virtually every project.
Our latest data platform, ScienceWire® v3, combines Discovery Logic's search and data mining technology, advanced algorithms and inter-source linkages among real-time open-source and proprietary databases including cross-agency R&D grant data, patents, citations, journals and news. We maintain and update these databases, create and apply algorithms to extract and link information across the databases, and deliver custom solutions that allow clients to apply the data to address their business needs.
Discovery Logic is agile, flexible, fast, and open to new challenges. We maintain an open organizational structure and free flows of communication. We hire extraordinarily talented individuals and give them the freedom to innovate. We pursue new opportunities quickly, challenging ourselves and our clients to think boldly.
|
Open
|
science, database, research, investment, metrics, grants, LRP, and loan repayment
|
Open
|
1375 Piccard Drive
|
Rockville
|
MD
|
US
|
20850
|
|
Thomson Reuters
|
Consumer Services
|
Media
|
nyse:tri
|
1507557
|
Apr 12th, 2024 12:00AM
|
Reuters Events Pharma
|
43K
|
14.00
|
Open
|
|
Apr 12th, 2024 01:20AM
|
Apr 12th, 2024 10:30AM
|
Reuters Events Pharma is a hub for senior-level pharma executives, patient advocacy groups and other health experts to exchange ideas and stay up to date with shifting trends and practices within the pharmaceutical industry. We provide industry-focused commentary, events, reports, and other valuable expert-driven content, around several key topic areas: marketing, commercial, data & analytics, patient engagement, patient advocacy, medical affairs, market access, RWE and clinical.
Our ultimate aim is to facilitate positive change through discussion and debate, enabling dialogue within the industry and driving the positive benefits that pharmaceuticals can offer. We actively respond to the aims and interests of our audience, so please get in touch if you think we can do even more.
One of Reuters Events Pharma's biggest strengths is to be able to gather opinion directly from industry executives themselves rather than the consultants and suppliers you see forming the majority of opinions in most pharmaceutical magazines and journals. We leverage this to provide unique features and thought-leadership, across the world.
Reuters Events is part of Reuters News.
|
Open
|
Newsletters, Events, Conferences, Reports, Market Intelligence, pharma marketing, digital pharma, whitepapers, virtual events, hybrid events, medical affairs, business intelligence, business insights, conferences, and webinars
|
Open
|
7-9 Fashion St
|
London
|
|
GB
|
E1 6PX
|
|
Thomson Reuters
|
Consumer Services
|
Media
|
nyse:tri
|
1400
|
Apr 12th, 2024 12:00AM
|
Thomson Reuters
|
1.7M
|
33089
|
Open
|
|
Apr 12th, 2024 01:20AM
|
Apr 12th, 2024 10:30AM
|
Thomson Reuters is the world’s leading provider of news and information-based tools to professionals. Our worldwide network of journalists and specialist editors keep customers up to speed on global developments, with a particular focus on legal, regulatory and tax changes.
Our customers operate in complex arenas that move society forward — tax, law, compliance, government, media. In a disruptive digital age, we help professionals reinvent themselves.
Thomson Reuters shares are listed on the Toronto and New York Stock Exchanges (symbol: TRI).
|
Open
|
Intelligent Information, Accounting, Legal, Tax, Media, Technology, and News
|
Open
|
19 Duncan Street
|
Toronto
|
ON
|
CA
|
M5H 3G6
|
|
Thomson Reuters
|
Consumer Services
|
Media
|
nyse:tri
|
1507557
|
Apr 11th, 2024 12:00AM
|
Reuters Events Pharma
|
43K
|
14.00
|
Open
|
|
Apr 11th, 2024 02:32AM
|
Apr 11th, 2024 01:12PM
|
Reuters Events Pharma is a hub for senior-level pharma executives, patient advocacy groups and other health experts to exchange ideas and stay up to date with shifting trends and practices within the pharmaceutical industry. We provide industry-focused commentary, events, reports, and other valuable expert-driven content, around several key topic areas: marketing, commercial, data & analytics, patient engagement, patient advocacy, medical affairs, market access, RWE and clinical.
Our ultimate aim is to facilitate positive change through discussion and debate, enabling dialogue within the industry and driving the positive benefits that pharmaceuticals can offer. We actively respond to the aims and interests of our audience, so please get in touch if you think we can do even more.
One of Reuters Events Pharma's biggest strengths is to be able to gather opinion directly from industry executives themselves rather than the consultants and suppliers you see forming the majority of opinions in most pharmaceutical magazines and journals. We leverage this to provide unique features and thought-leadership, across the world.
Reuters Events is part of Reuters News.
|
Open
|
Newsletters, Events, Conferences, Reports, Market Intelligence, pharma marketing, digital pharma, whitepapers, virtual events, hybrid events, medical affairs, business intelligence, business insights, conferences, and webinars
|
Open
|
7-9 Fashion St
|
London
|
|
GB
|
E1 6PX
|
|
Thomson Reuters
|
Consumer Services
|
Media
|